Gain the expertise to successfully implement patient-reported outcomes (PRO) measurement within drug development programs to generate patient-centered value messages. A well-formulated PRO strategy is critical for navigating regulatory, reimbursement, and market access challenges, requiring an understanding of instrument selection, psychometric evaluation, data capture, and interpretation.
